Fifty years and one full circle at Contract Pharmacal
By TOM MARINER // A familiar theme for success – and for staying on Long Island – is “family owned and operated.” Look no further than Contract Pharmacal Corp., which…
U.S. Food and Drug Administration
Bioscience ‘roller coaster’ racing toward new heights
By TOM MARINER // Broad Hollow Bioscience Park has already contributed mightily to Long Island’s “bio” ecosystem – and an old friend of regional commercialization is poised to take it…
A shocking discovery, with painfully obvious benefits
By GREGORY ZELLER // They’re getting down to the nitty gritty at the Feinstein Institutes for Medical Research, where investigators may have finally determined how and why electrical stimulation reduces…
Trip advisor: As ‘shrooms soar, proceed with caution
By JEFFREY REYNOLDS // If mere mention of “magic mushrooms” brings you back to blacklight posters, lava lamps and the rhythmic snare drum of Jefferson Airplane’s “White Rabbit,” you’re not…
Following COVID win, Island biotech targets monkeypox
By GREGORY ZELLER // Applied DNA Sciences is ready to play a little monkey ball. The Stony Brook-based biotech – part supply-chain authenticator, part Polymerase Chain Reaction-based DNA technology leader,…
Without gov’t oversight, who watches the pushers?
By TERRY LYNAM // Most people have a negative instinctive reaction to government bureaucracy and regulatory mandates, often viewed as excessively burdensome micromanagement. Many are inarguably flawed – but regulatory…
With Nassau in the PILOT seat, Acupath thinks bigger
By GREGORY ZELLER // A veteran Long Island biotech that found new footing during the COVID crisis is on the verge of a major expansion, with a tip of the…
Study: Even more promise in hot anticancer candidate
By GREGORY ZELLER // Stony Brook University researchers are reporting significant gains in the war on cancer – specifically, an anticancer drug showing real potential to reduce cancerous tumors. That’s…
Politics, truth and the lethal lie of ‘crack pipes for all’
By JEFFREY REYNOLDS // Was the federal government really planning to give away $30 million worth of taxpayer-funded crack pipes? No. But that didn’t stop The Washington Free Beacon from…
Albany OKs Applied DNA’s rapid Omicron detector
By GREGORY ZELLER // With the novel coronavirus reestablishing its national dominance, the New York State Department of Health has wasted no time greenlighting a Long Island biotech’s next-generation COVID-detection…
In Feinstein licensing deal, real movement on paralysis
By GREGORY ZELLER // The Feinstein Institutes for Medical Research has announced an exclusive licensing agreement with a medical-device startup harnessing the power of neurostimulation. Based on research conducted at…
Northwell’s new COVID-19 tests are pure LabGold
By GREGORY ZELLER // With a long-term focus on new screening programs for schools and underserved communities, Northwell Health is expanding use of self-administered COVID tests. Northwell Health Labs, the…
New collaboration gives Acupath wings, literally
By GREGORY ZELLER // Despite the lingering threat of COVID-19, Acupath has announced a world tour. Actually, the tour is because of that lingering threat. Acupath Laboratories, the Plainview-based diagnostics…
Innovation required as fatal overdoses spike again
By JEFFREY REYNOLDS // Everyone knows the definition of insanity is doing the same thing over and over again and expecting a different result. That’s why, as we address a…
Acupath COVID assay earns national Benasource bump
By GREGORY ZELLER // The United States, at long last, has COVID-19 cornered – national vaccinations have soared, while the New York State Department of Health on Wednesday reported the…